The gRNA Synthesis Market Size is valued at USD 492.4 Mn in 2023 and is predicted to reach USD 1,751.4 Mn by the year 2031 at an 17.4% CAGR during the forecast period for 2024 to 2031. gRNA Synthesis Market Size, Share & Trends Analysis Distribution by Product & Services (Products, Custom gRNA Synthesis Services), gRNA Type (Research-Use, GMP-grade), Application (Genome Engineering, Disease Model Studies, Functional Genomics, Epigenetics...
Report ID: 2735 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 176
Biologics CDMO Market Size is valued at USD 24.2 Bn in 2024 and is predicted to reach USD 125.5 Bn by the year 2034 at a 18.1% CAGR during the forecast period for 2025 to 2034. Biologics CDMO Market Size, Share & Trends Analysis Report By Cell Type (Mammalian, Non-mammalian), By Product Type (Biologics (Monoclonal Antibodies, Recombinant Proteins, Antisense and Molecular Therapy, Vaccines, Other Biologics, Biosimilars), By Region...
Report ID: 2233 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 180
Global Lutetium-177 Market Size is valued at USD 2.11 Bn in 2024 and is predicted to reach USD 7.41 Bn by the year 2034 at a 11.6% CAGR during the forecast period for 2025 to 2034. Lutetium-177 Market Size, Share & Trends Analysis Distribution by Application (Oncology, Non-Oncology), Type (No-Carrier-Added (NCA) Lu-177, Carrier-Added (CA) Lu-177), Product Type (Approved Drugs, Pipeline Drugs, Investigational Drugs), Scale of Operation (Precl...
Report ID: 3024 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 180
Global mRNA Synthesis Raw Materials Market Size is valued at USD 1.8 Bn in 2024 and is predicted to reach USD 3.4 Bn by the year 2034 at a 6.6% CAGR during the forecast period for 2025 to 2034.mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes, Others), By Application (Vaccine Production, Therapeutics Production, Others), By End-user (Biopharmaceutical & Phar...
Report ID: 1497 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 184
Global Gene Therapy Platform Market Size Was valued at USD 2.2 Bn in 2024 and is predicted to reach USD 9.8 Bn by 2034 at a 16.5% CAGR during the forecast period for 2025 to 2034. Gene Therapy Platform Market Size, Share & Trends Analysis Report, By Platform Type (Viral Vector Platforms, Non-Viral Vector Platforms), By Therapeutic Application, By Delivery Mode, By End Use, By Region, Forecasts, 2025 to 2034 Gene therapy's rapid ascent has...
Report ID: 3082 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 170
Global Regulatory Affairs Management for Cell and Gene Therapy Market Size is predicted to develop a 14.2% CAGR during the forecast period for 2025 to 2034. Regulatory Affairs Management for Cell and Gene Therapy Market, Share & Trends Analysis Report, By Service Type (In-house Regulatory Affairs, Outsourced Regulatory Affairs), By Application (Oncology, Rare Diseases, Genetic Disorders, Other Applications), By Therapy Type, By Region, and S...
Report ID: 3084 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 180
Spatiotemporal Omics Market Size is predicted to develop at an 12.3% CAGR during the forecast period for 2025 to 2034. Spatiotemporal Omics Market Size, Share & Trends Analysis Distribution by Technology (Spatial Transcriptomics, Spatial Genomics, Spatial Proteomics, Spatial Metabolomics, Others), Application (Cancer Research, Neuroscience, Drug Discovery and Development, Others) End-User (Academic and Research Institutes, Pharmaceutical and...
Report ID: 3085 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 180
VEGF Inhibitors Therapeutic for Diabetic Retinopathy Market Size is predicted to expand with a 6.8% CAGR during the forecast period for 2025 to 2034. VEGF Inhibitors Therapeutic for Diabetic Retinopathy Market, Share & Trends Analysis Report, By Drug Type (Aflibercept, Ranibizumab, Bevacizumab, Faricimab, Biosimilars, Pipeline drugs), By Indication (Diabetic Macular Edema (DME), Proliferative. Diabetic Retinopathy (PDR), Non-Proliferative Di...
Report ID: 3088 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 160
Global Real World Evidence (RWE) Oncology Market size is valued at USD 772.5 Mn in 2024 and is predicted to reach USD 2,373.9 Mn by the year 2034 at a 12.1% CAGR during the forecast period for 2025 to 2034. Real World Evidence (RWE) Oncology Market Size, Share & Trends Analysis Report By Component (Real-world Datasets, RWE Consulting & Analytics Services), Application (Drug Development & Approvals, Market Access, Post-market Surveill...
Report ID: 3093 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 170
RNAi Drug Delivery Market Size is valued at USD 108.8 Bn in 2024 and is predicted to reach USD 559.6 Bn by the year 2034 at a 18.1% CAGR during the forecast period for 2025 to 2034. RNAi Drug Delivery Market Size, Share & Trends Analysis By Target Disease ( Cancer, Metabolic Diseases, Genetic Disorders, Viral Infections, Others), By Technology (miRNA, siRNA, shRNA, Others), By Targeted Tissue (Heart, Brain, Liver, Lungs, Others), By Delivery...
Report ID: 3095 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 179
Pharmaceuticals